BCTX Stock Analysis: Buy, Sell, or Hold?
BCTX - Briacell Therapeutics Corp. Common Shares
$3.31
0.21 (6.77%)
▲
5d:
+10.7%
30d:
-9.07%
90d:
-19.85%
BUY
HIGH Confidence
Analysis Updated: Jun 30, 2026 12:00 AM ET
Earnings: Jun 15, 2026
0d
Get Alerted When BCTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: BCTX shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: BCTX shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
In-depth Analysis How we analyze
Valuation Analysis: BCTX is currently trading at $3.31, which is considered slightly high relative to its 30-day fair value range of $2.86 to $3.40.
Technical Outlook: Technically, BCTX is in a strong downtrend. The price is approaching resistance at $3.35. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 6.8% recently.
Market Sentiment: BCTX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $150.00 (+4738.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BCTX is in a strong downtrend. The price is approaching resistance at $3.35. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 6.8% recently.
Market Sentiment: BCTX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $150.00 (+4738.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$2.86 -
$3.40
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
84.2%
All Signals
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.8%)
- BULLISH: Trading 4738.7% below Wall St target ($150.00)
Trading Range Analysis
30-Day Trading Range
$2.86 -
$3.40
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$2.72
Resistance Level
$3.35
Current Trend
Strong Downtrend
Technical data as of
Jun 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.91
Wall Street Target
$150.00
(+4738.7%)
Share & Embed Analysis
Last updated: June 30, 2026 2:41 PM ET
Data refreshes hourly during market hours. Next update: 3:41 PM
Data refreshes hourly during market hours. Next update: 3:41 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BCTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$106 | 65 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$276 | 60 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 58 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$83 | 61 BUY |
